MRD negativity, assessed via next-generation sequencing, significantly improves progression-free survival in multiple myeloma patients, according to a UCSF study. Learn more ...

Genentech has acquired Regor Pharmaceuticals’ next-generation CDK inhibitors for breast cancer treatment in a deal worth ...

A study of Parkinson’s Disease patients undergoing DBS reveals that 40% develop peri-electrode oedema, with asleep surgery ...

MRD negativity and clonal diversity significantly improve survival outcomes in multiple myeloma, offering insights for ...

NEW research highlights a significant advancement in HIV vaccine development: a two-dose priming strategy that optimizes the body’s immune response by aligning vaccine delivery with the germinal ...

A protective sleeve developed for axillary osmidrosis surgery reduces skin damage, such as bruising and erosion, compared to ...

Could the adoption of cutting-edge imaging technologies and innovative use of existing methods revolutionize the diagnosis ...

Rate this content's potential impact on patient outcomes Submit Rating Thank you! Please share some more information on the ...

A study has revealed triptans are the most effective medicine for adults experiencing acute migraine. Read more ...

A study from Memorial Sloan Kettering identifies a 6% risk of second primary malignancies in CAR T-cell therapy patients for ...

Discover an automated speech analysis platform that has been developed to test for minimal hepatic encephalopathy (HE) and to ...

A study highlights that GLP-1 RAs are linked to a reduced risk of cirrhosis in patients with MASLD and diabetes. Learn more ...